Metroplex Clinical Research Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis3 trials
• Psoriasis2 trials
• Psoriatic arthritis2 trials
• Gout1 trial
• Osteoarthritis1 trial

Phase

• Phase 32 trials
• Phase 42 trials
• Phase 11 trial

Status

• Completed4 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Galvani Bioelectronics1 trial
• Janssen Research & Development, LLC1 trial
• Jeffrey Curtis1 trial
• LG Chem1 trial
• and 1 more

Running trials

• Active, not recruiting

  Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee

  NCT04119687· Phase 1· Pacira Pharmaceuticals, Inc· Source

Closed trials

• Completed

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· Phase 3· LG Chem· Source

• Completed

  COVID-19 VaccinE Response in Rheumatology Patients

  NCT05080218· Phase 4· Jeffrey Curtis· Source

• Recruiting

  ConsideRAte Study - Splenic Stimulation for RA

  NCT05003310· Galvani Bioelectronics· Source

  Contact: Operations Director

• Completed

  Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

  NCT04936308· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Baricitinib in Participants With Rheumatoid Arthritis

  NCT04086745· Phase 4· Eli Lilly and Company· Source